NGEN · Nervgen Pharma Corp. · Exempt Offerings
Market Cap
$234.94M
Shares
107.52M
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
| Filed | Type | Industry | Offering | Sold | Exemptions |
|---|---|---|---|---|---|
| 2021-12-14 | New | Other | $1,052,930 | $651,815 | 06b |
| 2021-08-25 | Amendment | Other | $5,357,419 | $2,194,379 | 06b |
| 2021-08-17 | New | Other | $442,322 | $263,692 | 06b |
| 2021-06-02 | Amendment | Other | $650,123 | $285,141 | 06b |
| 2020-08-25 | New | Other | $5,357,419 | $2,194,379 | 06b |
| 2020-06-03 | New | Other | $650,123 | $285,141 | 06b |
Showing 1–6 of 6 filings